| Application no. and date | 12805725.4 (espacenet) (Federated) (European Patent Register), 20121214 | | Patent/reg. no. and date | DK/EP 2791129, 20151007 | | Publication date | 20141022 | | Priority no. and date | GB 201121557, 20111215 | | EP pub. no. and date |
EP 2791129 20141022 | | Effective date | | | Applicant/owner | Atopix Therapeutics Limited, 265 Strand
London WC2R 1BH, GB | | Applicant ref. no. | P21777DKEP | | Inventor | BURGOS, Alain, 9 Impasse Le Pin
F-69230 Saint Genis-laval, FR,
TONNEL, Jacques, Chemin de pla
F-66200 Elne, FR,
PINTUS, Tony, 18 rue de la Prée au Lin
F-49070 Saint Jean de Linières, FR | | Representative | Patrade A/S, Ceresbyen 75, 8000 Århus C | | Opponent | | | IPC Class | C07D 401/06 (2006.01) | | Title | Fremgangsmåde til fremstilling af (5-fluoro-2-methyl-3-quinolin-2-ylmetyl-indol-1-yl)-eddikesyreestre | | Int. application no. | GB2012000903 | | Int. publication no. | WO2013088108 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
